Journal
JOURNAL OF IMMUNOLOGY
Volume 173, Issue 4, Pages 2227-2230Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.173.4.2227
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI48779, AI54610] Funding Source: Medline
- NINDS NIH HHS [NS45445, NS23444, NS23221] Funding Source: Medline
Ask authors/readers for more resources
CD4(+)CD25(+) regulatory T cells are crucial to the maintenance of tolerance in normal individuals. However, the factors regulating this cell population and its function are largely unknown. Estrogen has been shown to protect against the development of autoimmune disease, yet the mechanism is not known. We demonstrate that estrogen (17-beta-estradiol, E2) is capable of augmenting FoxP3 expression in vitro and in vivo. Treatment of naive mice with E2 increased both CD25(+) cell number and FoxP3 expression level Further, the ability of E2 to protect against autoimmune disease (experimental autoimmune encephalomyelitis) correlated with its ability to up-regulate FoxP3, as both were reduced in estrogen receptor a-deficient animals. Finally, E2 treatment and pregnancy induced FoxP3 protein expression to a similar degree, suggesting that high estrogen levels during pregnancy may help to maintain fetal tolerance. In summary, our data suggest E2 promotes tolerance by expanding the regulatory T cell compartment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available